DBV Technologies ADR (NASDAQ: DBVT) started the day on Wednesday, with a price increase of 25.42% at $22.55, before settling in for the price of $17.98 at the close. Taking a more long-term approach, DBVT posted a 52-week range of $2.74-$21.50.
The Healthcare sector firm’s twelve-monthly sales growth has been 24.08% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 24.08%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -60.77%. This publicly-traded company’s shares outstanding now amounts to $40.14 million, simultaneously with a float of $32.94 million. The organization now has a market capitalization sitting at $905.16 million. At the time of writing, stock’s 50-day Moving Average stood at $15.15, while the 200-day Moving Average is $10.41.
DBV Technologies ADR (DBVT) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. DBV Technologies ADR’s current insider ownership accounts for 17.94%, in contrast to 33.81% institutional ownership. According to the most recent insider trade that took place on Nov 20 ’25, this organization’s Chief Medical Officer sold 6,496 shares at the rate of 2.88, making the entire transaction reach 18,708 in total value, affecting insider ownership by 103,153. Preceding that transaction, on Nov 21 ’25, Company’s Chief Medical Officer sold 1,624 for 2.77, making the whole transaction’s value amount to 4,498. This particular insider is now the holder of 101,529 in total.
DBV Technologies ADR (DBVT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
DBV Technologies ADR’s EPS decrease for this current 12-month fiscal period is -60.77% and is forecasted to reach -0.34 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 38.85% through the next 5 years, which can be compared against the 24.08% growth it accomplished over the previous five years trading on the market.
DBV Technologies ADR (NASDAQ: DBVT) Trading Performance Indicators
Let’s observe the current performance indicators for DBV Technologies ADR (DBVT). It’s Quick Ratio in the last reported quarter now stands at 1.80. In the same vein, DBVT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -5.24, a figure that is expected to reach -0.20 in the next quarter, and analysts are predicting that it will be -0.34 at the market close of one year from today.
Technical Analysis of DBV Technologies ADR (DBVT)
If we take a close look at the recent performances of DBV Technologies ADR (NASDAQ: DBVT), its last 5-days Average volume was 1.2 million that shows progress from its year to date volume of 0.22 million. During the previous 9 days, stock’s Stochastic %D was recorded 64.86% While, its Average True Range was 81.53.
Raw Stochastic average of DBV Technologies ADR (DBVT) in the period of the previous 100 days is set at 79.43%, which indicates a major rise in contrast to 72.94% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.54 that was higher than 0.95 volatility it exhibited in the past 100-days period.
